cGxP.wire https://validator.w3.org/feed/docs/rss2.html U.S. Renal Care Presents Eight Kidney Research Studies at ASN Resonant Launches Sample Asset Management Programs for Trial CoSara HPV Test Study Highlights Cervical Cancer Screening Novo Nordisk to Present 26 Obesity Data Abstracts at 2026 Instylla Wins FDA Approval for Embrace Bleeding Device Azitra Expands ATR-04 Trial for Cancer-Related Skin Rashes Abbott Launches Pivotal Trial of Cephea Mitral Valve Johnson & Johnson Presents 26 Impella Studies at TCT 2026! BioMarin Licenses Next-Gen Fabry Disease Therapy Worldwide Sobi Reports Positive Phase 3 Pozdeutinurad Gout Data US WorldMeds Acquires Orbus to Advance Glioma Drug Research Eli Lilly Retatrutide Shows Strong Phase 3 Diabetes Results! Palvella Gains FDA Priority Review for QTORIN Rapamycin NDA! Novo Nordisk to Present 12 New Liver Research Abstracts HotSpot Therapeutics to Present HST-2011 Autoimmune Data Avenzo to Present AVZO-023 Phase 1 Results at SABCS 2026 Immunome Receives EMA Validation for Varegacestat Application Propanc Advances PPC-001 Assay Development for Phase 1b Cancer Study Moleculin Completes MIRACLE Trial Part A Dosing in R/R AML Atsena Reports Promising ATSN-301 Preclinical Data for Usher 1B Syndax’s Revuforj Wins 2026 Prix Galien Rare Disease Award Pelthos to Merge With Castle Creek, Expanding Skin Disease Pipeline Denali Therapeutics Wins 2026 Prix Galien Award for AVLAYAH Setara Biosciences Raises $90M Series A to Advance Rare Disease Drugs Alkermes Initiates Phase 2 Study of ALKS 7290 in Depression Latus Bio Reports Engineered AAV Capsid Data for Kidney and CNS Diseases Brainomix AI Finds Stroke Signals in CHARM Phase 3 Trial Genprex to Present TUSC2 Gene Research at GSA 2026 Meeting Formation Bio Launches $600M Fund to Advance Drug Development Agios Sets February 2027 FDA Goal Date for Mitapivat in Sickle Cell Disease Boehringer Ingelheim Launches Metabolic Matters Initiative Ascletis Reports Strong ASC30 Phase 2 Diabetes Results HERVolution Advances HERV-K Cancer Immunotherapy Research TransCode Taps Tungsten for Oncology Portfolio Review NRx Pharmaceuticals Receives FDA Approval for Preservative-Free Ketamine SetPoint Medical Performs First Boston RA Implant Procedure Novo Nordisk to Present New Wegovy Liver Research Empatica Launches WellPD for At-Home Parkinson’s Monitoring Acumen Pharmaceuticals Ends Sabirnetug Development After Phase 2 Failure Suvoda Expands Greenphire Travel to Support Trial Patients Teva Acquires BioXcel Assets to Expand Neuroscience Pipeline Leads Biolabs Doses First SLE Patient in LBL-047 Phase 1 Trial Ferring to Acquire Gameto in $1.38 Billion Deal Arrowhead Secures UK Access for REDEMPLO in FCS Alpheus Reports New Blood Biomarker Research in Glioblastoma CellsBin Wins NCI Award to Advance Myeloma Blood Test Nyra Medical Expands Leadership as CARLEN Trial Advances AcuraStem Secures $1M Award to Advance AS-241 for ALS Tangram Therapeutics Doses First Participant in Phase 1 TGM-148 Clinical Trial OneOncology Reports Outpatient Tarlatamab Safety Findings